ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 132 filers reported holding ANAPTYSBIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $607,685 | -67.1% | 27,991 | -53.2% | 0.01% | -70.4% |
| Q4 2022 | $1,849,789 | +21.3% | 59,767 | 0.0% | 0.03% | +12.5% |
| Q3 2022 | $1,525,000 | +25.7% | 59,767 | 0.0% | 0.02% | +41.2% |
| Q2 2022 | $1,213,000 | -18.9% | 59,767 | -1.1% | 0.02% | -5.6% |
| Q1 2022 | $1,495,000 | -28.1% | 60,448 | +2.5% | 0.02% | -21.7% |
| Q4 2021 | $2,078,000 | +30.0% | 58,954 | 0.0% | 0.02% | +27.8% |
| Q3 2021 | $1,599,000 | +4.6% | 58,954 | 0.0% | 0.02% | +12.5% |
| Q2 2021 | $1,529,000 | – | 58,954 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $65,033,000 | 13.01% |
| EcoR1 Capital, LLC | 7,521,024 | $186,070,000 | 5.82% |
| GREAT POINT PARTNERS LLC | 700,000 | $17,318,000 | 4.18% |
| Frazier Life Sciences Management, L.P. | 899,700 | $22,259,000 | 1.90% |
| Boxer Capital, LLC | 1,300,000 | $32,162,000 | 1.65% |
| Logos Global Management LP | 300,000 | $7,422,000 | 0.96% |
| Deep Track Capital, LP | 558,782 | $13,824,000 | 0.89% |
| Palo Alto Investors LP | 431,024 | $10,664,000 | 0.82% |
| TCG Crossover Management, LLC | 58,515 | $1,448,000 | 0.58% |
| Rock Springs Capital Management LP | 563,300 | $13,936,000 | 0.35% |